MDR1 (P-glycoprotein) gene expression--implications for resistance modifier trials

Editorial

P R Twentyman. J Natl Cancer Inst. 1992.

. 1992 Oct 7;84(19):1458-60.

doi: 10.1093/jnci/84.19.1458.

No abstract available

Comment on

Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas.
Holzmayer TA, Hilsenbeck S, Von Hoff DD, Roninson IB. Holzmayer TA, et al. J Natl Cancer Inst. 1992 Oct 7;84(19):1486-91. doi: 10.1093/jnci/84.19.1486. J Natl Cancer Inst. 1992. PMID: 1359152
Effect of P-glycoprotein expression on sensitivity to hormones in MCF-7 human breast cancer cells.
Clarke R, Currier S, Kaplan O, Lovelace E, Boulay V, Gottesman MM, Dickson RB. Clarke R, et al. J Natl Cancer Inst. 1992 Oct 7;84(19):1506-12. doi: 10.1093/jnci/84.19.1506. J Natl Cancer Inst. 1992. PMID: 1359153